Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Orforglipron

ATTAIN-J

Eli Lilly · Phase 3 · Completed · Enrollment 238

NCT05931380

ArmNauseaVomitingDiarrheaDiscontinuationDeaths
Placebo QD0 participants0 participants2 participantsn/r0
6 mg Orforglipron QD8 participants4 participants9 participantsn/r0
12 mg Orforglipron QD9 participants5 participants4 participantsn/r0
36 mg Orforglipron QDn/rn/rn/rn/rn/r

A count stays a count. This page does not turn a count into a percent.